MADISON, N.J., Aug. 5, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Canaccord Genuity 36th Annual Growth Conference in Boston, Massachusetts. Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Wednesday, August 10, 2016 at 10:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://wsw.com/webcast/canaccord23/dgx and to the public on www.QuestDiagnostics.com. In addition, the archived webcast will be available within 1 hour after the conclusion of the live event and will remain available until September 9, 2016.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 44,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Shawn Bevec (Investors): 973-520-2900
Dennis Moynihan (Media): 973-520-2800
SOURCE Quest Diagnostics